C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/64 (2006.01) A61K 39/095 (2006.01) A61K 39/21 (2006.01) A61K 39/295 (2006.01) A61K 39/385 (2006.01) C07K 7/08 (2006.01) C07K 14/155 (2006.01) C07K 14/16 (2006.01) C07K 14/22 (2006.01) C07K 16/10 (2006.01) C07K 17/06 (2006.01) C12N 7/04 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2139517
Immunological conjugates of HIV-specific selected principal neutralization epitopes are prepared. These epitopes bind a broadly neutralizing human monoclonal antibody specific for the HIV principal neutralization epitope(s) and are identified from oligopeptide epitope libraries. The conjugates are useful for vaccination against AIDS or ARC, as well as in the production of other HIV-specific broadly neutralizing antibodies for passive immunity against AIDS or ARC.
Arnold Beth A.
Conley Anthony J.
Keller Paul M.
Shaw Alan R.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Immunological conjugates of ompc and hiv-specific selected... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunological conjugates of ompc and hiv-specific selected..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological conjugates of ompc and hiv-specific selected... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2047898